Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism.
Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism.
Front Horm Res. 2019;51:52-62
Authors: Vannucci L, Brandi ML
Abstract
Familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT) are genetically determined variants of primary hyperparathyroidism. FHH usually has a benign course, and patients do not require treatment, whereas NSHPT is a severe disorder often requiring early parathyroidectomy for young patients to survive. Recent discoveries in the genetic basis and new findings in therapeutic approaches have led to a great interest in these rare diseases.
PMID: 30641521 [PubMed - in process]
Source: Frontiers of Hormone Research - Category: Endocrinology Tags: Front Horm Res Source Type: research
More News: Endocrinology | Genetics | Hormones | Hyperparathyroidism | Parathyroidectomy | Perinatology & Neonatology | Rare Diseases